Industry Research Reports

Home > Reports > Service & Software > AI Drug Discovery Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

AI Drug Discovery Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-03-12

Pages: 111 Pages

Report ld: 4649909

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

AI Drug Discovery Software Market Size(US$)

CAGR 2025-2031

14%

Market Size,2031

USD 1,260

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 574 million

Market Forecast in 2031(Value)

US$ 1,260 million

CAGR

14%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for AI Drug Discovery Software was estimated to be worth US$ 510 million in 2024 and is forecast to a readjusted size of US$ 1260 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.

AI drug discovery software is a software tool that accelerates the drug development process by utilizing artificial intelligence algorithms and technologies. This software integrates and analyzes a vast amount of bioinformatics data, chemical structure data, and clinical trial data to predict key properties such as compound bioactivity, pharmacokinetic characteristics, and toxicity. With the help of AI technology, drug researchers can more quickly and accurately screen potential candidate drugs, thereby reducing development costs, shortening development cycles, and improving success rates.

North American market for AI Drug Discovery Software was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for AI Drug Discovery Software was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for AI Drug Discovery Software was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of AI Drug Discovery Software include Nanolive, TandemAI, Benevolent, Atomwise, Cradle, Exscientia, Iktos, Insilico Medicine, Collaborative Drug Discovery, Valence Labs, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for AI Drug Discovery Software, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI Drug Discovery Software by region & country, by Type, and by Application.

The AI Drug Discovery Software market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Drug Discovery Software.

MARKET SEGMENTATION

By Company

Nanolive
TandemAI
Benevolent
Atomwise
Cradle
Exscientia
Iktos
Insilico Medicine
Collaborative Drug Discovery
Valence Labs
Certara
Insilico
Genentech
Merck

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cloud Based
On Premise

Segment by Application

CRO and Universities
Pharmaceutical Company
Test Lab

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of AI Drug Discovery Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of AI Drug Discovery Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of AI Drug Discovery Software in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 AI Drug Discovery Software Product Introduction

1.2 Global AI Drug Discovery Software Market Size Forecast (2020-2031)

1.3 AI Drug Discovery Software Market Trends & Drivers

1.3.1 AI Drug Discovery Software Industry Trends

1.3.2 AI Drug Discovery Software Market Drivers & Opportunity

1.3.3 AI Drug Discovery Software Market Challenges

1.3.4 AI Drug Discovery Software Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global AI Drug Discovery Software Players Revenue Ranking (2024)

2.2 Global AI Drug Discovery Software Revenue by Company (2020-2025)

2.3 Key Companies AI Drug Discovery Software Manufacturing Base Distribution and Headquarters

2.4 Key Companies AI Drug Discovery Software Product Offered

2.5 Key Companies Time to Begin Mass Production of AI Drug Discovery Software

2.6 AI Drug Discovery Software Market Competitive Analysis

2.6.1 AI Drug Discovery Software Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by AI Drug Discovery Software Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Discovery Software as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Cloud Based

3.1.2 On Premise

3.2 Global AI Drug Discovery Software Sales Value by Type

3.2.1 Global AI Drug Discovery Software Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global AI Drug Discovery Software Sales Value, by Type (2020-2031)

3.2.3 Global AI Drug Discovery Software Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 CRO and Universities

4.1.2 Pharmaceutical Company

4.1.3 Test Lab

4.2 Global AI Drug Discovery Software Sales Value by Application

4.2.1 Global AI Drug Discovery Software Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global AI Drug Discovery Software Sales Value, by Application (2020-2031)

4.2.3 Global AI Drug Discovery Software Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global AI Drug Discovery Software Sales Value by Region

5.1.1 Global AI Drug Discovery Software Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global AI Drug Discovery Software Sales Value by Region (2020-2025)

5.1.3 Global AI Drug Discovery Software Sales Value by Region (2026-2031)

5.1.4 Global AI Drug Discovery Software Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America AI Drug Discovery Software Sales Value, 2020-2031

5.2.2 North America AI Drug Discovery Software Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe AI Drug Discovery Software Sales Value, 2020-2031

5.3.2 Europe AI Drug Discovery Software Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific AI Drug Discovery Software Sales Value, 2020-2031

5.4.2 Asia Pacific AI Drug Discovery Software Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America AI Drug Discovery Software Sales Value, 2020-2031

5.5.2 South America AI Drug Discovery Software Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa AI Drug Discovery Software Sales Value, 2020-2031

5.6.2 Middle East & Africa AI Drug Discovery Software Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions AI Drug Discovery Software Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions AI Drug Discovery Software Sales Value, 2020-2031

6.3 United States

6.3.1 United States AI Drug Discovery Software Sales Value, 2020-2031

6.3.2 United States AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

6.3.3 United States AI Drug Discovery Software Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe AI Drug Discovery Software Sales Value, 2020-2031

6.4.2 Europe AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe AI Drug Discovery Software Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China AI Drug Discovery Software Sales Value, 2020-2031

6.5.2 China AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

6.5.3 China AI Drug Discovery Software Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan AI Drug Discovery Software Sales Value, 2020-2031

6.6.2 Japan AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan AI Drug Discovery Software Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea AI Drug Discovery Software Sales Value, 2020-2031

6.7.2 South Korea AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea AI Drug Discovery Software Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia AI Drug Discovery Software Sales Value, 2020-2031

6.8.2 Southeast Asia AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia AI Drug Discovery Software Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India AI Drug Discovery Software Sales Value, 2020-2031

6.9.2 India AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

6.9.3 India AI Drug Discovery Software Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Nanolive

7.1.1 Nanolive Profile

7.1.2 Nanolive Main Business

7.1.3 Nanolive AI Drug Discovery Software Products, Services and Solutions

7.1.4 Nanolive AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.1.5 Nanolive Recent Developments

7.2 TandemAI

7.2.1 TandemAI Profile

7.2.2 TandemAI Main Business

7.2.3 TandemAI AI Drug Discovery Software Products, Services and Solutions

7.2.4 TandemAI AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.2.5 TandemAI Recent Developments

7.3 Benevolent

7.3.1 Benevolent Profile

7.3.2 Benevolent Main Business

7.3.3 Benevolent AI Drug Discovery Software Products, Services and Solutions

7.3.4 Benevolent AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.3.5 Benevolent Recent Developments

7.4 Atomwise

7.4.1 Atomwise Profile

7.4.2 Atomwise Main Business

7.4.3 Atomwise AI Drug Discovery Software Products, Services and Solutions

7.4.4 Atomwise AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.4.5 Atomwise Recent Developments

7.5 Cradle

7.5.1 Cradle Profile

7.5.2 Cradle Main Business

7.5.3 Cradle AI Drug Discovery Software Products, Services and Solutions

7.5.4 Cradle AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.5.5 Cradle Recent Developments

7.6 Exscientia

7.6.1 Exscientia Profile

7.6.2 Exscientia Main Business

7.6.3 Exscientia AI Drug Discovery Software Products, Services and Solutions

7.6.4 Exscientia AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.6.5 Exscientia Recent Developments

7.7 Iktos

7.7.1 Iktos Profile

7.7.2 Iktos Main Business

7.7.3 Iktos AI Drug Discovery Software Products, Services and Solutions

7.7.4 Iktos AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.7.5 Iktos Recent Developments

7.8 Insilico Medicine

7.8.1 Insilico Medicine Profile

7.8.2 Insilico Medicine Main Business

7.8.3 Insilico Medicine AI Drug Discovery Software Products, Services and Solutions

7.8.4 Insilico Medicine AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.8.5 Insilico Medicine Recent Developments

7.9 Collaborative Drug Discovery

7.9.1 Collaborative Drug Discovery Profile

7.9.2 Collaborative Drug Discovery Main Business

7.9.3 Collaborative Drug Discovery AI Drug Discovery Software Products, Services and Solutions

7.9.4 Collaborative Drug Discovery AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.9.5 Collaborative Drug Discovery Recent Developments

7.10 Valence Labs

7.10.1 Valence Labs Profile

7.10.2 Valence Labs Main Business

7.10.3 Valence Labs AI Drug Discovery Software Products, Services and Solutions

7.10.4 Valence Labs AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.10.5 Valence Labs Recent Developments

7.11 Certara

7.11.1 Certara Profile

7.11.2 Certara Main Business

7.11.3 Certara AI Drug Discovery Software Products, Services and Solutions

7.11.4 Certara AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.11.5 Certara Recent Developments

7.12 Insilico

7.12.1 Insilico Profile

7.12.2 Insilico Main Business

7.12.3 Insilico AI Drug Discovery Software Products, Services and Solutions

7.12.4 Insilico AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.12.5 Insilico Recent Developments

7.13 Genentech

7.13.1 Genentech Profile

7.13.2 Genentech Main Business

7.13.3 Genentech AI Drug Discovery Software Products, Services and Solutions

7.13.4 Genentech AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.13.5 Genentech Recent Developments

7.14 Merck

7.14.1 Merck Profile

7.14.2 Merck Main Business

7.14.3 Merck AI Drug Discovery Software Products, Services and Solutions

7.14.4 Merck AI Drug Discovery Software Revenue (US$ Million) & (2020-2025)

7.14.5 Merck Recent Developments

8 Industry Chain Analysis

8.1 AI Drug Discovery Software Industrial Chain

8.2 AI Drug Discovery Software Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 AI Drug Discovery Software Sales Model

8.5.2 Sales Channel

8.5.3 AI Drug Discovery Software Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. AI Drug Discovery Software Market Trends

Table 2. AI Drug Discovery Software Market Drivers & Opportunity

Table 3. AI Drug Discovery Software Market Challenges

Table 4. AI Drug Discovery Software Market Restraints

Table 5. Global AI Drug Discovery Software Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global AI Drug Discovery Software Revenue Market Share by Company (2020-2025)

Table 7. Key Companies AI Drug Discovery Software Manufacturing Base Distribution and Headquarters

Table 8. Key Companies AI Drug Discovery Software Product Type

Table 9. Key Companies Time to Begin Mass Production of AI Drug Discovery Software

Table 10. Global AI Drug Discovery Software Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Discovery Software as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global AI Drug Discovery Software Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global AI Drug Discovery Software Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global AI Drug Discovery Software Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global AI Drug Discovery Software Sales Market Share in Value by Type (2020-2025)

Table 17. Global AI Drug Discovery Software Sales Market Share in Value by Type (2026-2031)

Table 18. Global AI Drug Discovery Software Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global AI Drug Discovery Software Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global AI Drug Discovery Software Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global AI Drug Discovery Software Sales Market Share in Value by Application (2020-2025)

Table 22. Global AI Drug Discovery Software Sales Market Share in Value by Application (2026-2031)

Table 23. Global AI Drug Discovery Software Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global AI Drug Discovery Software Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global AI Drug Discovery Software Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global AI Drug Discovery Software Sales Value by Region (2020-2025) & (%)

Table 27. Global AI Drug Discovery Software Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions AI Drug Discovery Software Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions AI Drug Discovery Software Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions AI Drug Discovery Software Sales Value, (2026-2031) & (US$ Million)

Table 31. Nanolive Basic Information List

Table 32. Nanolive Description and Business Overview

Table 33. Nanolive AI Drug Discovery Software Products, Services and Solutions

Table 34. Revenue (US$ Million) in AI Drug Discovery Software Business of Nanolive (2020-2025)

Table 35. Nanolive Recent Developments

Table 36. TandemAI Basic Information List

Table 37. TandemAI Description and Business Overview

Table 38. TandemAI AI Drug Discovery Software Products, Services and Solutions

Table 39. Revenue (US$ Million) in AI Drug Discovery Software Business of TandemAI (2020-2025)

Table 40. TandemAI Recent Developments

Table 41. Benevolent Basic Information List

Table 42. Benevolent Description and Business Overview

Table 43. Benevolent AI Drug Discovery Software Products, Services and Solutions

Table 44. Revenue (US$ Million) in AI Drug Discovery Software Business of Benevolent (2020-2025)

Table 45. Benevolent Recent Developments

Table 46. Atomwise Basic Information List

Table 47. Atomwise Description and Business Overview

Table 48. Atomwise AI Drug Discovery Software Products, Services and Solutions

Table 49. Revenue (US$ Million) in AI Drug Discovery Software Business of Atomwise (2020-2025)

Table 50. Atomwise Recent Developments

Table 51. Cradle Basic Information List

Table 52. Cradle Description and Business Overview

Table 53. Cradle AI Drug Discovery Software Products, Services and Solutions

Table 54. Revenue (US$ Million) in AI Drug Discovery Software Business of Cradle (2020-2025)

Table 55. Cradle Recent Developments

Table 56. Exscientia Basic Information List

Table 57. Exscientia Description and Business Overview

Table 58. Exscientia AI Drug Discovery Software Products, Services and Solutions

Table 59. Revenue (US$ Million) in AI Drug Discovery Software Business of Exscientia (2020-2025)

Table 60. Exscientia Recent Developments

Table 61. Iktos Basic Information List

Table 62. Iktos Description and Business Overview

Table 63. Iktos AI Drug Discovery Software Products, Services and Solutions

Table 64. Revenue (US$ Million) in AI Drug Discovery Software Business of Iktos (2020-2025)

Table 65. Iktos Recent Developments

Table 66. Insilico Medicine Basic Information List

Table 67. Insilico Medicine Description and Business Overview

Table 68. Insilico Medicine AI Drug Discovery Software Products, Services and Solutions

Table 69. Revenue (US$ Million) in AI Drug Discovery Software Business of Insilico Medicine (2020-2025)

Table 70. Insilico Medicine Recent Developments

Table 71. Collaborative Drug Discovery Basic Information List

Table 72. Collaborative Drug Discovery Description and Business Overview

Table 73. Collaborative Drug Discovery AI Drug Discovery Software Products, Services and Solutions

Table 74. Revenue (US$ Million) in AI Drug Discovery Software Business of Collaborative Drug Discovery (2020-2025)

Table 75. Collaborative Drug Discovery Recent Developments

Table 76. Valence Labs Basic Information List

Table 77. Valence Labs Description and Business Overview

Table 78. Valence Labs AI Drug Discovery Software Products, Services and Solutions

Table 79. Revenue (US$ Million) in AI Drug Discovery Software Business of Valence Labs (2020-2025)

Table 80. Valence Labs Recent Developments

Table 81. Certara Basic Information List

Table 82. Certara Description and Business Overview

Table 83. Certara AI Drug Discovery Software Products, Services and Solutions

Table 84. Revenue (US$ Million) in AI Drug Discovery Software Business of Certara (2020-2025)

Table 85. Certara Recent Developments

Table 86. Insilico Basic Information List

Table 87. Insilico Description and Business Overview

Table 88. Insilico AI Drug Discovery Software Products, Services and Solutions

Table 89. Revenue (US$ Million) in AI Drug Discovery Software Business of Insilico (2020-2025)

Table 90. Insilico Recent Developments

Table 91. Genentech Basic Information List

Table 92. Genentech Description and Business Overview

Table 93. Genentech AI Drug Discovery Software Products, Services and Solutions

Table 94. Revenue (US$ Million) in AI Drug Discovery Software Business of Genentech (2020-2025)

Table 95. Genentech Recent Developments

Table 96. Merck Basic Information List

Table 97. Merck Description and Business Overview

Table 98. Merck AI Drug Discovery Software Products, Services and Solutions

Table 99. Revenue (US$ Million) in AI Drug Discovery Software Business of Merck (2020-2025)

Table 100. Merck Recent Developments

Table 101. Key Raw Materials Lists

Table 102. Raw Materials Key Suppliers Lists

Table 103. AI Drug Discovery Software Downstream Customers

Table 104. AI Drug Discovery Software Distributors List

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

List of Figures

Figure 1. AI Drug Discovery Software Product Picture

Figure 2. Global AI Drug Discovery Software Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global AI Drug Discovery Software Sales Value (2020-2031) & (US$ Million)

Figure 4. AI Drug Discovery Software Report Years Considered

Figure 5. Global AI Drug Discovery Software Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by AI Drug Discovery Software Revenue in 2024

Figure 7. AI Drug Discovery Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Cloud Based Picture

Figure 9. On Premise Picture

Figure 10. Global AI Drug Discovery Software Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global AI Drug Discovery Software Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of CRO and Universities

Figure 13. Product Picture of Pharmaceutical Company

Figure 14. Product Picture of Test Lab

Figure 15. Global AI Drug Discovery Software Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global AI Drug Discovery Software Sales Value Market Share by Application, 2024 & 2031

Figure 17. North America AI Drug Discovery Software Sales Value (2020-2031) & (US$ Million)

Figure 18. North America AI Drug Discovery Software Sales Value by Country (%), 2024 VS 2031

Figure 19. Europe AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 20. Europe AI Drug Discovery Software Sales Value by Country (%), 2024 VS 2031

Figure 21. Asia Pacific AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 22. Asia Pacific AI Drug Discovery Software Sales Value by Region (%), 2024 VS 2031

Figure 23. South America AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 24. South America AI Drug Discovery Software Sales Value by Country (%), 2024 VS 2031

Figure 25. Middle East & Africa AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 26. Middle East & Africa AI Drug Discovery Software Sales Value by Country (%), 2024 VS 2031

Figure 27. Key Countries/Regions AI Drug Discovery Software Sales Value (%), (2020-2031)

Figure 28. United States AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 29. United States AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

Figure 30. United States AI Drug Discovery Software Sales Value by Application (%), 2024 VS 2031

Figure 31. Europe AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 32. Europe AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

Figure 33. Europe AI Drug Discovery Software Sales Value by Application (%), 2024 VS 2031

Figure 34. China AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 35. China AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

Figure 36. China AI Drug Discovery Software Sales Value by Application (%), 2024 VS 2031

Figure 37. Japan AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 38. Japan AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

Figure 39. Japan AI Drug Discovery Software Sales Value by Application (%), 2024 VS 2031

Figure 40. South Korea AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 41. South Korea AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

Figure 42. South Korea AI Drug Discovery Software Sales Value by Application (%), 2024 VS 2031

Figure 43. Southeast Asia AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 44. Southeast Asia AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

Figure 45. Southeast Asia AI Drug Discovery Software Sales Value by Application (%), 2024 VS 2031

Figure 46. India AI Drug Discovery Software Sales Value, (2020-2031) & (US$ Million)

Figure 47. India AI Drug Discovery Software Sales Value by Type (%), 2024 VS 2031

Figure 48. India AI Drug Discovery Software Sales Value by Application (%), 2024 VS 2031

Figure 49. AI Drug Discovery Software Industrial Chain

Figure 50. AI Drug Discovery Software Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global AI Drug Discovery Software market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global AI Drug Discovery Software market is 14% 2025 to 2031.

What was the global market size of AI Drug Discovery Software in 2031? shouQi

What was the global market size of AI Drug Discovery Software in 2025? shouQi

Which companies rank high in the global AI Drug Discovery Software market? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global AI Drug Discovery Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI Drug Discovery Software market is projected to grow from US$ 862 million in 2025 to US$ 2429 million by 2032, at a CAGR of 15.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 137
USD 4900.00
(Single User License)
Global AI Drug Discovery Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Drug Discovery Software market size was US$ 862 million in 2025 and is forecast to reach a readjusted size of US$ 2429 million by 2032 with a CAGR of 15.7% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 99
USD 4250.00
(Single User License)
Global AI Drug Discovery Software Market Research Report 2026
The global AI Drug Discovery Software market was valued at US$ 862 million in 2025 and is anticipated to reach US$ 2429 million by 2032, at a CAGR of 15.7% from 2026 to 2032.
Published Date: 2026-01-20
Pages: 111
USD 2900.00
(Single User License)
AI Drug Discovery Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Discovery Software was estimated to be worth US$ 862 million in 2025 and is projected to reach US$ 2429 million, growing at a CAGR of 15.7% from 2026 to 2032.
Published Date: 2026-01-20
Pages: 111
USD 3950.00
(Single User License)
Global AI Drug Discovery Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Drug Discovery Software market size was US$ 510 million in 2024 and is forecast to a readjusted size of US$ 1260 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 93
USD 4250.00
(Single User License)
Global AI Drug Discovery Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Discovery Software market is projected to grow from US$ 510 million in 2024 to US$ 1260 million by 2031, at a CAGR of 14.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 139
USD 4900.00
(Single User License)
Global AI Drug Discovery Software Market Research Report 2025
The global market for AI Drug Discovery Software was valued at US$ 510 million in the year 2024 and is projected to reach a revised size of US$ 1260 million by 2031, growing at a CAGR of 14.0% during the forecast period.
Published Date: 2025-03-12
Pages: 81
USD 2900.00
(Single User License)
Global AI Drug Discovery Software Market Insights, Forecast to 2030
The global AI Drug Discovery Software market is projected to grow from US$ 510 million in 2024 to US$ 1119 million by 2030, at a Compound Annual Growth Rate (CAGR) of 14.0% during the forecast period.
Published Date: 2024-11-12
Pages: 138
USD 4900.00
(Single User License)
Global and United States AI Drug Discovery Software Market Report & Forecast 2024-2030
The global AI Drug Discovery Software revenue was US$ 470 million in 2023 and is forecast to a readjusted size of US$ 1119 million by 2030 with a CAGR of 14.0% during the review period (2024-2030).
Published Date: 2024-11-12
Pages: 108
USD 4350.00
(Single User License)
AI Drug Discovery Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Discovery Software was estimated to be worth US$ 470 million in 2023 and is forecast to a readjusted size of US$ 1119 million by 2030 with a CAGR of 14.0% during the forecast period 2024-2030.
Published Date: 2024-11-12
Pages: 119
USD 3950.00
(Single User License)

Global AI Drug Discovery Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI Drug Discovery Software market is projected to grow from US$ 862 million in 2025 to US$ 2429 million by 2032, at a CAGR of 15.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 137
USD 4900.00 (Single User License)
Global AI Drug Discovery Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Drug Discovery Software market size was US$ 862 million in 2025 and is forecast to reach a readjusted size of US$ 2429 million by 2032 with a CAGR of 15.7% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 99
USD 4250.00 (Single User License)
Global AI Drug Discovery Software Market Research Report 2026
The global AI Drug Discovery Software market was valued at US$ 862 million in 2025 and is anticipated to reach US$ 2429 million by 2032, at a CAGR of 15.7% from 2026 to 2032.
Published: 2026-01-20
Pages: 111
USD 2900.00 (Single User License)
AI Drug Discovery Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Drug Discovery Software was estimated to be worth US$ 862 million in 2025 and is projected to reach US$ 2429 million, growing at a CAGR of 15.7% from 2026 to 2032.
Published: 2026-01-20
Pages: 111
USD 3950.00 (Single User License)
Global AI Drug Discovery Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Drug Discovery Software market size was US$ 510 million in 2024 and is forecast to a readjusted size of US$ 1260 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 93
USD 4250.00 (Single User License)
Global AI Drug Discovery Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Drug Discovery Software market is projected to grow from US$ 510 million in 2024 to US$ 1260 million by 2031, at a CAGR of 14.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 139
USD 4900.00 (Single User License)
Global AI Drug Discovery Software Market Research Report 2025
The global market for AI Drug Discovery Software was valued at US$ 510 million in the year 2024 and is projected to reach a revised size of US$ 1260 million by 2031, growing at a CAGR of 14.0% during the forecast period.
Published: 2025-03-12
Pages: 81
USD 2900.00 (Single User License)
Global AI Drug Discovery Software Market Insights, Forecast to 2030
The global AI Drug Discovery Software market is projected to grow from US$ 510 million in 2024 to US$ 1119 million by 2030, at a Compound Annual Growth Rate (CAGR) of 14.0% during the forecast period.
Published: 2024-11-12
Pages: 138
USD 4900.00 (Single User License)
Global and United States AI Drug Discovery Software Market Report & Forecast 2024-2030
The global AI Drug Discovery Software revenue was US$ 470 million in 2023 and is forecast to a readjusted size of US$ 1119 million by 2030 with a CAGR of 14.0% during the review period (2024-2030).
Published: 2024-11-12
Pages: 108
USD 4350.00 (Single User License)
AI Drug Discovery Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for AI Drug Discovery Software was estimated to be worth US$ 470 million in 2023 and is forecast to a readjusted size of US$ 1119 million by 2030 with a CAGR of 14.0% during the forecast period 2024-2030.
Published: 2024-11-12
Pages: 119
USD 3950.00 (Single User License)